Microfluidic Technology Market to Grow to $29.41 Billion; Health technology market identified as parent market

0

NEW YORK, November 21, 2022 /PRNewswire/ — The “Microfluidic Technology Market by Material and Geography – Forecast and Analysis 2022-2026report has been added to Technavio’s offering. The report forecasts the market size to increase by $29.41 billion accelerating at a CAGR of 19.42% during the forecast period. Technavio classifies the global microfluidic technology market as part of the global health technology market, which, in turn, is part of the global healthcare market. The market includes revenue generated from the sales of healthcare IT applications and systems, internet-based healthcare tools (such as monitoring devices) and IT consulting services to clinics, hospitals or companies primarily operating in the health sector. Technavio calculates the size of the global health technology market based on the combined revenue generated by manufacturers/suppliers of equipment, supplies, pharmaceuticals, biotechnology, health technology players and tools and life science services. Get more highlights in parent market analysis. Download a Free Sample PDF Report

Technavio has announced its latest market research report titled Global Microfluidics Technology Market 2022-2026

Microfluidic Technology Market 2022-2026: Scope

Technavio presents a detailed picture of the market through study, synthesis and summation of data from multiple sources. The Microfluidic Technology Market report covers the following areas:

Technavio’s library includes over 17,000 reports covering over 2,000 emerging technologies. Subscribe to our “Basic Plan” right now $5,000 and get lifetime access to our Technavio Insights

Microfluidic Technology Market 2022-2026: Scope

The global microfluidic technology market is highly fragmented, with small and large vendors operating in a highly competitive environment. Market players compete on various factors such as price, brand, availability, and variety. Price is a major basis for competition among players to gain market advantage. The growth of market players also depends on market conditions, government support and industry development. Access to capital and advances in product innovation are major barriers to entry for new players. Therefore, suppliers need to expand geographically and boost domestic demand to achieve sustained growth over time. Suppliers can increase their profitability by practicing efficient production techniques to minimize product costs and avoid cost overruns. There are a significant number of smaller regional providers in the market. Intense competition and declining profit margins are significant risk factors for vendors. Therefore, to survive and succeed in this fiercely competitive environment, it becomes imperative for vendors to differentiate their product and service offerings through clear and unique value propositions. Get more insights into the vendor landscape. Download a Free Sample PDF Report

Microfluidic Technology Market 2022-2026: Segmentation

The global microfluidic technology market is segmented as follows:

The polymer-based microfluidics segment will have the largest market share. Over the past decade, there have been significant advances in PMMA microfluidic chips. PMMA microchips are expected to find a wide range of applications in the healthcare industry and lead to the creation of truly disposable microfluidic devices. Thus, increased adoption of polymer-based microfluidics in various healthcare applications is driving the growth of the global microfluidic technology market in this segment.

Hospitals are the main end users of the market. The hospital segment in which microfluidic technology can serve as autologous material for cell replacement therapies or even future organ transplants, with the ability to correct disease-causing mutations prior to transplantation. Microfluidic technology will revolutionize precision diagnostic approaches and future drug development in diagnostic centers.

33% of market growth will come from North America during the forecast period. The market in North America generates the highest revenue in the global microfluidic technology market. The region is dominated by the United States, Canadaand Mexico. One of the factors driving the high demand for this market in the United States is the high investment in health research and testing.

Technavio’s in-depth research covers all your needs, as our research reports include all foreseeable market scenarios, including pre and post-COVID-19 analysis. Buy now!

Microfluidic Technology Market 2022-2026: Vendor Analysis

Competitors should focus on differentiating their product offerings with unique value propositions to strengthen their market presence. Market sellers also need to take advantage of existing growth prospects in fast-growing segments, while maintaining their positions in slow-growing segments.

Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Biocartis Group NV, BioFluidix GmbH, Blacktrace Holdings Ltd., Cellix Ltd., Danaher Corp., Elveflow, Epigem Ltd., F. Hoffmann La Roche Ltd., Fluigent SA, iBiochips, IDEX Corp., Illumina Inc., PerkinElmer Inc., QIAGEN NV, SMC Corp., Standard BioTools Inc., and Thermo Fisher Scientific Inc. are some of the major market players. Understand how purchasing the report can directly impact your revenue. Download a free sample report now

Microfluidic Technology Market 2022-2026: Key Highlights

  • Market CAGR over the forecast period 2022-2026

  • In-depth information on factors that will contribute to the growth of the Microfluidic Technology market over the next five years

  • Estimation of the Microfluidic Technology market size and its contribution to the parent market

  • Predictions on upcoming trends and changes in consumer behavior

  • The growth of the microfluidic technology market

  • Market Competitive Landscape Analysis and Detailed Vendor Information

  • Comprehensive details of the factors that will challenge the growth of the Microfluidic Technology Market vendors

Related reports:

  • The Antibodies and Neuroscience Testing Market is a comprehensive research document that provides in-depth qualitative and quantitative information. Technavio analysts estimate the market share growth of $1837.68 million from 2022 to 2027 at a CAGR of 9.44%. The increasing incidence of neurological disorders is notably driving the growth of the neuroscientific antibodies and testing market, although factors such as the high development cost of neuroscientific antibodies may hamper the market growth.

  • The biomedical refrigerators and freezers market share is expected to increase by $1.27 billion from 2021 to 2026, and the growth momentum of the market will accelerate at a CAGR of 6.04%. The presence of value-added software and hardware products is particularly driving the growth of the biomedical refrigerators and freezers market, although factors such as compliance with medical guidelines and declining number of blood donors may hamper the market growth.

Scope of Microfluidic Technology Market

Report cover

Details

Page number

120

Year of reference

2021

Forecast period

2022-2026

Growth momentum and CAGR

Accelerate at a CAGR of 19.42%

Market Growth 2022-2026

$29.41 billion

Market structure

Fragmented

Annual growth (%)

18.71

Regional analysis

North America, Europe, Asia and Rest of the World (ROW)

Successful market contribution

North America at 33%

Main consumer countries

USA, Canada, UK, Germany and China

Competitive landscape

Leading companies, competitive strategies, scope of consumer engagement

Profiled companies

Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Biocartis Group NV, BioFluidix GmbH, Blacktrace Holdings Ltd., Cellix Ltd., Danaher Corp., Elveflow, Epigem Ltd., F. Hoffmann La Roche Ltd. , Fluigent SA, iBiochips, IDEX Corp., Illumina Inc., PerkinElmer Inc., QIAGEN NV, SMC Corp., Standard BioTools Inc. and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, market growth drivers and barriers, analysis of fast and slow growing segments, impact of COVID-19 and future consumer dynamics, and analysis of market conditions for the forecast period.

Personalization area

If our report does not include the data you are looking for, you can contact our analysts and customize the segments.

Contents:

1. Summary

2 Market landscape

3 Market sizing

4 Five forces analysis

5 Market Segmentation by Material

6 Market Segmentation by End User

7 Customer Landscape

8 Geographic landscape

9 drivers, challenges and trends

10 Supplier Landscape

11 Vendor Analysis

12 Appendix

About Us

Technavio is a global leader in technology research and consulting. Their research and analysis focuses on emerging market trends and provides actionable insights to help companies identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialist analysts, Technavio’s reporting library consists of over 17,000 reports and counts, spanning 800 technologies, spanning 50 countries. Their customer base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing customer base relies on Technavio’s comprehensive coverage, in-depth research, and actionable market intelligence to identify opportunities in existing markets and potentials and assess their competitive positions in changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Manager
USA: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

Global Microfluidic Technology Market 2022-2026

Global Microfluidic Technology Market 2022-2026

Quote

Quote

View original content to download multimedia: https://www.prnewswire.com/news-releases/microfluidics-technology-market-to-record-usd-29-41-bn-growth-healthcare-technology-market-identified -as -parent-market—technavio-301681715.html

SOURCETechnavio

Share.

About Author

Comments are closed.